Volume 72, Issue 2, Pages (February 2016)

Slides:

Advertisements

Similar presentations

Reduced Intensity Versus Myelo-Ablative Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic.

Advertisements

Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with.

Hematopoietic Stem Cell Transplantation in Australia and New Zealand,

A matched case–control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication A. Conrad,

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year.

Trend, Risk Factors and Outcome of Thrombotic Microangiopathy in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review

Norovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation Recipients: Incidence, Risk Factors, and Outcome Joseph Delano F. Robles, Daniel.

Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock T. Ferry, D. Thomas,

Volume 18, Issue 1, Pages (January 2016)

Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow.

Relative Survival of Long-Term Hematopoietic Cell Transplant Recipients Approaches General Population Rates Ian Nivison-Smith, Judy M. Simpson, Anthony.

G. Catho, S. Couraud, S. Grard, A. Bouaziz, A. Sénéchal, F. Valour, T

Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients Takahiro.

A matched case–control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication A. Conrad,

Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells.

Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide,

Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome Lise Willems, Raphaël.

Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock T. Ferry, D. Thomas,

The Prognostic Value of YKL-40 Concentrations in Nonmyeloablative Conditioning Allogeneic Hematopoietic Cell Transplantation Anne Mette Mørup, Brian.

Direct Conversion of Skin Cells into Blood: Alchemy or Science?

J. S. Casalegno, M. Ottmann, M. Bouscambert Duchamp, V. Escuret, G

Clinical Utility of Wilms' Tumor 1 Monitoring in Patients with Myeloid Malignancy and Prior Allogeneic Hematopoietic Stem Cell Transplantation Kazuko.

J. S. Casalegno, M. Ottmann, M. Bouscambert Duchamp, V. Escuret, G

Hematopoietic Stem Cell Transplantation after Reduced Intensity Conditioning in Acute Myelogenous Leukemia Patients Older Than 40 Years Cynthia Huisman,

Long-Term Immune Reconstitution and Infection Burden after Mismatched Hematopoietic Stem Cell Transplantation Sophie Servais, Etienne Lengline, Raphaël.

Sabina Kersting, Leo F. Verdonck

Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non- Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic.

A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation

Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute

Betty T. Tran, Abigail Halperin, Jason W. Chien

David C. Yao, MD, PhD, Paolo Caimi, MD, Hillard M

Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation in Children Coco de Koning, Maud Plantinga, Paul Besseling, Jaap Jan Boelens,

Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources Christopher M. Walker,

A Population-Based Cohort Study of Late Mortality in Adult Autologous Hematopoietic Stem Cell Transplant Recipients in Australia Lesley J. Ashton, Renate.

Lymphocyte Subset Recovery and Outcome after Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma Jessica Rueff, Michael Medinger,

Biology of Blood and Marrow Transplantation

Total Marrow Lymphoid Irradiation/Fludarabine/ Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation Lindsay G. Jensen, Tracey Stiller,

Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies Robert.

Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter.

Long-Term Outcomes of Critically Ill Adult Allogeneic Hematopoietic Stem Cell Recipients Prakash Vishnu, Udit Roy, Pramod Guru, Colleen Thomas, Candido.

Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome Haesook T. Kim, Philippe Armand,

Is There a Role for Autologous Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia? A Retrospective Analysis Nicolas Novitzky, Valda.

Peripheral Blood Lymphocyte and Monocyte Recovery and Survival in Acute Leukemia Postmyeloablative Allogeneic Hematopoietic Stem Cell Transplant Mary.

Risk Factors for Late Infections after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Related Donor Marie Robin, Raphaël Porcher,

Relationship of BK Polyoma Virus (BKV) in the Urine with Hemorrhagic Cystitis and Renal Function in Recipients of T Cell–Depleted Peripheral Blood and.

Viral Respiratory Infections Diagnosed by Multiplex PCR after Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Incidence and Outcome Alice.

Sabina Kersting, Ronald J. Hené, Hein A. Koomans, Leo F. Verdonck

Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.

Disparity in Survival Outcome after Hematopoietic Stem Cell Transplantation for Hematologic Malignancies According to Area of Primary Residence Keshav.

Shigeo Fuji, Hermann Einsele, Bipin N. Savani, Markus Kapp

Impact of Donor and Recipient Sex and Parity on Outcomes of HLA-Identical Sibling Allogeneic Hematopoietic Stem Cell Transplantation Alison W. Loren,

Prolonged Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation and Its Association with a Reduction in Ploidy and an Immaturation.

Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation Aline Clavert, Zinaida Peric, Eolia.

Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa Barbara.

Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data Brent R. Logan, Mei-Jie Zhang,

The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion

What is quality in a transplant program?

Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD–Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-

Liver transplantation in children

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute.

IFN-α Is Effective for Treatment of Minimal Residual Disease in Patients with Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation:

A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome Peggy A. Wu,

Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:

Higher Total Nucleated Cell Dose, but Not CD3+, 4+, 8+, or 34+ Cell Dose, Is Associated with Better Overall and Progression-Free Survival after Allogeneic.

Monitoring Mixed Lineage Leukemia Expression May Help Identify Patients with Mixed Lineage Leukemia–Rearranged Acute Leukemia Who Are at High Risk of.

Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based.

Chromosomally Integrated Human Herpesvirus 6: Transmission via Cord Blood-Derived Unrelated Hematopoietic Stem Cell Transplantation P.J. de Pagter, Anne.

Hematopoietic Stem Cell Transplantation in Australia and New Zealand,

Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion Franck E. Nicolini, Eric Wattel, Anne-Sophie.

Futility of Relapsed Diffuse Large B Cell Lymphoma Transplantation?

Presentation transcript:

Volume 72, Issue 2, Pages 214-222 (February 2016) HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns Adrien Quintela, Vanessa Escuret, Sandrine Roux, Pascale Bonnafous, Lila Gilis, Fiorenza Barraco, Hélène Labussière-Wallet, Sophie Duscastelle-Leprêtre, Franck-Emmanuel Nicolini, Xavier Thomas, Christian Chidiac, Tristan Ferry, Emilie Frobert, Stéphane Morisset, Françoise Poitevin-Later, Guillaume Monneret, Mauricette Michallet, Florence Ader F. Ader, E. Bachy, M. Balsat, F. Barraco, A.L. Bienvenu, G. Billaud, F. Biron, A. Boibieux, C. Chidiac, A. Conrad, S. Ducastelle-Leprêtre, O. Dumitrescu, D. Dupont, V. Escuret, T. Ferry, E. Frobert, L. Gilis, A. Grateau, M. Heiblig, H. Labussière-Wallet, M. Le Maréchal, L. Lebras, B. Lina, G. Lina, A. Quintela, P. Miailhes, A.-S. Michallet, M. Michallet, M.-C. Michallet, G. Monneret, F. Morfin-Sherpa, F.E. Nicolini, T. Perpoint, M. Peyrouse de Montclos, S. Picot, F. Poitevin-Later, A.G. Ranc, S. Roux, G. Salles, J. Saison, A. Sénéchal, M. Sobh, X. Thomas, F. Valour, E. Wattel Adrien Quintela, Vanessa Escuret, Sandrine Roux, Pascale Bonnafous, Lila Gilis, Fiorenza Barraco, Hélène Labussière-Wallet, Sophie Duscastelle-Leprêtre, Franck-Emmanuel Nicolini, Xavier Thomas, Christian Chidiac, Tristan Ferry, Emilie Frobert, Stéphane Morisset, Françoise Poitevin-Later, Guillaume Monneret, Mauricette Michallet, Florence Ader F. Ader, E. Bachy, M. Balsat, F. Barraco, A.L. Bienvenu, G. Billaud, F. Biron, A. Boibieux, C. Chidiac, A. Conrad, S. Ducastelle-Leprêtre, O. Dumitrescu, D. Dupont, V. Escuret, T. Ferry, E. Frobert, L. Gilis, A. Grateau, M. Heiblig, H. Labussière-Wallet, M. Le Maréchal, L. Lebras, B. Lina, G. Lina, A. Quintela, P. Miailhes, A.-S. Michallet, M. Michallet, M.-C. Michallet, G. Monneret, F. Morfin-Sherpa, F.E. Nicolini, T. Perpoint, M. Peyrouse de Montclos, S. Picot, F. Poitevin-Later, A.G. Ranc, S. Roux, G. Salles, J. Saison, A. Sénéchal, M. Sobh, X. Thomas, F. Valour, E. Wattel Journal of Infection Volume 72, Issue 2, Pages 214-222 (February 2016) DOI: 10.1016/j.jinf.2015.09.039 Copyright © 2015 The British Infection Association Terms and Conditions

Figure 1 (a) Cumulative incidence of HHV-6 infections in allogeneic hematopoietic stem cell transplantation recipients over time according to stem cell sources; (b) probability of overall survival after allo-HSCT according to active HHV-6 active infection. Journal of Infection 2016 72, 214-222DOI: (10.1016/j.jinf.2015.09.039) Copyright © 2015 The British Infection Association Terms and Conditions

Figure 2 Peripheral blood T lymphocyte recovery at 3- (M3), 6- (6M), and 12-months (12M) after allo-HSCT measured by T lymphocyte counts expressed in number/μL (left panel) and percentages (right panel): (a and b) CD4+ lymphocytes; (c and d) CD8+ lymphocytes. Journal of Infection 2016 72, 214-222DOI: (10.1016/j.jinf.2015.09.039) Copyright © 2015 The British Infection Association Terms and Conditions